Goldenwell Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 17, 2023 at 12:28 pm EDT
Goldenwell Biotech, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 0.000276 million compared to USD 0.003713 million a year ago. Net loss was USD 0.027084 million compared to USD 0.0268 million a year ago.
For the six months, sales was USD 0.001698 million compared to USD 0.00411 million a year ago. Net loss was USD 0.06069 million compared to USD 0.06018 million a year ago.